Immune to Cancer: The CRI Blog
-
Multiple Myeloma Awareness Month: 2022 Immunotherapy Research Updates
This March for Multiple Myeloma Awareness Month, discover the latest treatments, research insights, and progress for a…
-
Overcoming Immune Dysfunction in Brain Cancer with CRI Lloyd J. Old STAR Peter Fecci
CRI Arash Ferdowsi Lloyd J. Old STAR Peter Fecci is seeking to characterize and develop ways to…
-
CRI Scientist’s “Rosetta Stone” Tech Unlocks New Era
Dr. Alex Marson, a CRI-funded STAR, has developed a new genetic screening technology with potential to significantly…
-
Crossing the Country to Cure Cancer
Jarad Schofer became intrigued by the idea of walking across America and decided to raise money for…
-
Engineering Bacteria to Improve Cancer Immunotherapy with CRI Lloyd J. Old STAR Tal Danino
CRI Lloyd J. Old STAR Tal Danino is exploring how to engineer bacteria to help our bodies…
-
CRI Highlights First Recipients of Postdoctoral Fellowship to Promote Racial Diversity in Immuno-Oncology
Meet three promising young scientists changing the face of immuno-oncology: Ryan K. Alexander, PhD, of Boston Children’s…
-
Cervical Cancer Awareness Month: 2022 Immunotherapy Research Updates
New research, new treatments, and how we’re working toward a future immune to cervical cancer
-
COVID-19 and Cancer Vaccines with Immunotherapy Pioneers Ugur Sahin and Özlem Türeci
Ugur Sahin and Ozlem Tureci, two of this year’s CRI Coley Award recipients, are pioneers of the…
-
Dr. Dmitriy Zamarin Answers Questions About Ovarian Cancer and Immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Dmitriy Zamarin, of Memorial Sloan Kettering Cancer Center, answers questions about immunotherapy clinical trials from the…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.